BRD2 and Testicular atrophy: Of those with unfavorable testicular histopathology, 47/50 (94%) had elevated FSH levels, and 42/50 (84%) had testicular atrophy, while 21/36 (58.3%) had elevated FSH levels, and 26/36 (72%) had testicular atrophy in the favorable pathology group.